A NON-INFERIORITY STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF COMBINATION DRY POWDER OF FLUTICASONE PROPIONATE AND SALMETEROL (FSC) 250/50 MICROGRAM (MCG) TWICE DAILY (BID) IN ADULTS AND ADOLESCENTS WITH ASTHMA: